Imatinib cancer drug

Imatinib cancer drug

A624/0430 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 41.9MB

Downloadable file size: 642.1KB

Price image Pricing

Please login to use the price calculator


Caption: Imatinib cancer drug, molecular model. This drug, marketed as Gleevac or Glivac, is used to treat several cancers, including chronic myelogenous leukaemia and gastrointestinal stromal tumours. It inhibits a form of tyrosine kinase enzyme, which is responsible for promoting the growth of certain tumours. By blocking the enzyme's active site, it prevents the proliferation of tumour cells. It also encourages the enzyme to enter the cell nucleus, where it cannot prevent the suicide (apotosis) of cancer cells. In this model, atoms are represented by coloured spheres; carbon is green, hydrogen is white, nitrogen is blue, and oxygen is red.

Release details: Model release not required. Property release not required.

Keywords: anticancer, artwork, biochemical, biochemistry, biological, biology, cancer, chemical, chemistry, chemotherapy, chronic myelogenous, clinical, cml, competitive antagonist, compound, compounds, computer artwork, drug, gastrointestinal stromal, gist, gleevac, glivac, illustration, imatinib, inhibitor, inhibits, leukaemia, leukemia, malignancies, malignant, medical, medicine, molecular, molecular model, molecule, molecules, oncology, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, single, space fill, spacefill, sphere, spheres, structure, tk, treatment, tumour, tumours, tyrosine kinase

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.